Showing results (1781-1790 of 8,963) with videos related to
Sort By:
Pageof 897
Journal of Hepatology|July 19, 2017
Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosisRoberto Carnevale, Valeria Raparelli, Cristina Nocella, et al.Journal of Hepatology|November 5, 2017
Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axisJulia Pollmann, Jana-Julia Götz, Daniel Rupp, et al.Journal of Hepatology|November 7, 2017
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control studyGyuri Kim, Suk-Yong Jang, Chung Mo Nam, et al.Journal of Hepatology|October 29, 2017
A novel orally available small molecule that inhibits hepatitis B virus expressionHenrik Mueller, Steffen Wildum, Souphalone Luangsay, et al.Journal of Hepatology|October 30, 2017
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in EuropeHannah Fraser, Natasha K Martin, Henrikki Brummer-Korvenkontio, et al.Journal of Hepatology|October 30, 2017
Gα12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cellsKyu Min Kim, Chang Yeob Han, Ji Young Kim, et al.Journal of Hepatology|October 17, 2017
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovationsJean-Charles Nault, Olivier Sutter, Pierre Nahon, et al.Journal of Hepatology|November 15, 2017
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis CPeter Buggisch, Johannes Vermehren, Stefan Mauss, et al.Journal of Hepatology|November 11, 2017
Genetics and epigenetics of NAFLD and NASH: Clinical impactMohammed Eslam, Luca Valenti, Stefano RomeoJournal of Hepatology|November 11, 2017
Pharmacotherapy for NASH: Current and emergingMonica A Konerman, Jacob C Jones, Stephen A HarrisonPageof 897